Found: 6
Select item for more details and to access through your institution.
EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41392-019-0059-4
- By:
- Publication type:
- Article
Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1585-2
- By:
- Publication type:
- Article
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00347-9
- By:
- Publication type:
- Article
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00850-2
- By:
- Publication type:
- Article
CK1δ stimulates ubiquitination‐dependent proteasomal degradation of ATF4 to promote chemoresistance in gastric Cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.587
- By:
- Publication type:
- Article
Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition.
- Published in:
- Theranostics, 2021, v. 11, n. 17, p. 8464, doi. 10.7150/thno.60028
- By:
- Publication type:
- Article